A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin
Publication date: October 2026 Source: Research and Practice in Thrombosis and Haemostasis, Volume 10, Issue 7 Author(s): Maria Teresa Pagliari, Luciano Baronciani, Paola Colpani, Giovanna Cozzi, Omid Seidizadeh, Alessandro Ciavarella, Simona Maria Siboni, Flora Peyvandi
A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036290?dgcid=rss_sd_all
A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036290?dgcid=rss_sd_all
“A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin.” Research and Practice in Thrombosis and Haemostasis.
@article{article119482,
title = {A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036290?dgcid=rss_sd_all}
}